Increase/Decrease in Cash: The total change in cash for the company over the given period.
IMMURON (IMRN) had Increase/Decrease in Cash of $4.20M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$8.79M |
|
-- |
|
-- |
|
$8.93M |
|
$1.21M |
|
-- |
|
$0.14M |
|
$1.35M |
|
$7.58M |
|
$7.58M |
|
$7.58M |
|
-- |
|
| Cash Flow Statement Financials | |
$-2.21M |
|
$2.20M |
|
$4.39M |
|
$1.92M |
|
$6.12M |
|
|
Increase/Decrease in Cash |
$4.20M |
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|